These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3729124)

  • 41. Immune responses of breeding chickens to trivalent oil emulsion vaccines: responses to Newcastle disease and infectious bursal disease.
    Wyeth PJ; Gough RE; Cullen GA
    Vet Rec; 1981 Jan; 108(4):72-5. PubMed ID: 6266123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of inactivated oil-emulsion vaccines with avian viral or Mycoplasma antigens.
    Stone HD; Brugh M; Hopkins SR; Yoder HW; Beard CW
    Avian Dis; 1978; 22(4):666-74. PubMed ID: 219830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy of the B-1 and VG/GA vaccine strains against velogenic viscerotropic Newcastle disease virus in chickens.
    Beard CW; Villegas P; Glisson JR
    Avian Dis; 1993; 37(1):222-5. PubMed ID: 8452500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
    Gagic M; St Hill CA; Sharma JM
    Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continued studies on the adjuvancy effect of natural and synthetic double-stranded RNA preparations with inactivated Newcastle disease vaccines in fowls.
    Knight DJ; Leiper JW; Gough RE; Allan WH
    Res Vet Sci; 1977 Jul; 23(1):38-42. PubMed ID: 905652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
    Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tween 80-solubilized Newcastle disease virus prepared as a water-in-oil-in-water vaccine.
    Cajavec S; Bidin Z; Sladić D; Pokrić B
    Avian Dis; 1996; 40(1):193-201. PubMed ID: 8713034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization of hydrophile-lipophile balance for improved efficacy of Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone HD
    Avian Dis; 1988; 32(1):68-73. PubMed ID: 3382382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of adjuvants on oral vaccination of chickens against Newcastle disease.
    Rehmani SF; Spradbrow PB
    Vet Microbiol; 1995 Sep; 46(1-3):63-8. PubMed ID: 8545980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody response of kori bustards (Ardeotis kori) and houbara bustards (Chlamydotis undulata) to live and inactivated Newcastle disease vaccines.
    Bailey TA; Wernery U; Samour JH; Naldo JL
    J Zoo Wildl Med; 1998 Dec; 29(4):441-50. PubMed ID: 10065854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-response effects of inactivated Newcastle disease vaccines: influence of serologic assay, time after vaccination, and type of chickens.
    Maas RA; Oei HL; Venema-Kemper S; Koch G; Bongers J
    Avian Dis; 1999; 43(4):670-7. PubMed ID: 10611983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure- and oil type-based efficacy of emulsion adjuvants.
    Jansen T; Hofmans MP; Theelen MJ; Manders F; Schijns VE
    Vaccine; 2006 Jun; 24(26):5400-5. PubMed ID: 16675072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken.
    Linghua Z; Xingshan T; Fengzhen Z
    Vet Immunol Immunopathol; 2007 Feb; 115(3-4):216-22. PubMed ID: 17157392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation.
    Lambrecht B; Gonze M; Meulemans G; van den Berg TP
    Avian Pathol; 2004 Jun; 33(3):343-50. PubMed ID: 15223565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laboratory trials with inactivated vaccines against Escherichia coli (O2:K1) infection in fowls.
    Deb JR; Harry EG
    Res Vet Sci; 1978 May; 24(3):308-13. PubMed ID: 353924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvanticity of epimedium polysaccharide-propolis flavone on inactivated vaccines against AI and ND virus.
    Fan Y; Wang D; Liu J; Hu Y; Zhao X; Han G; Nguyen TL; Chang S
    Int J Biol Macromol; 2012 Dec; 51(5):1028-32. PubMed ID: 22935524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of IR rays on the titers and protein fractions of the blood serum in chicks vaccinated with La Sota vaccine].
    Bodurova T
    Vet Med Nauki; 1975; 12(4):88-94. PubMed ID: 1216684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant.
    Fatunmbi OO; Newman JA; Sivanandan V; Halvorson DA
    Vaccine; 1992; 10(9):623-6. PubMed ID: 1502840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.